These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 39037244)

  • 41. Astroglial water channel aquaporin 4-mediated glymphatic clearance function: A determined factor for time-sensitive treatment of aerobic exercise in patients with Alzheimer's disease.
    Yin M; Pu T; Wang L; Marshall C; Wu T; Xiao M
    Med Hypotheses; 2018 Oct; 119():18-21. PubMed ID: 30122483
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma oligomer beta-amyloid is associated with disease severity and cerebral amyloid deposition in Alzheimer's disease spectrum.
    Wang SM; Kang DW; Um YH; Kim S; Lee CU; Scheltens P; Lim HK
    Alzheimers Res Ther; 2024 Mar; 16(1):55. PubMed ID: 38468313
    [TBL] [Abstract][Full Text] [Related]  

  • 43. P38K and JNK pathways are induced by amyloid-β in astrocyte: Implication of MAPK pathways in astrogliosis in Alzheimer's disease.
    Saha P; Guha S; Biswas SC
    Mol Cell Neurosci; 2020 Oct; 108():103551. PubMed ID: 32896578
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TRPA1 channels promote astrocytic Ca
    Bosson A; Paumier A; Boisseau S; Jacquier-Sarlin M; Buisson A; Albrieux M
    Mol Neurodegener; 2017 Jul; 12(1):53. PubMed ID: 28683776
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oligomeric amyloid β preferentially targets neuronal and not glial mitochondrial-encoded mRNAs.
    Mastroeni D; Nolz J; Khdour OM; Sekar S; Delvaux E; Cuyugan L; Liang WS; Hecht SM; Coleman PD
    Alzheimers Dement; 2018 Jun; 14(6):775-786. PubMed ID: 29396107
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Astrocyte Transforming Growth Factor Beta 1 Protects Synapses against Aβ Oligomers in Alzheimer's Disease Model.
    Diniz LP; Tortelli V; Matias I; Morgado J; Bérgamo Araujo AP; Melo HM; Seixas da Silva GS; Alves-Leon SV; de Souza JM; Ferreira ST; De Felice FG; Gomes FCA
    J Neurosci; 2017 Jul; 37(28):6797-6809. PubMed ID: 28607171
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amyloid beta-protein (Abeta)-containing astrocytes are located preferentially near N-terminal-truncated Abeta deposits in the human entorhinal cortex.
    Thal DR; Schultz C; Dehghani F; Yamaguchi H; Braak H; Braak E
    Acta Neuropathol; 2000 Dec; 100(6):608-17. PubMed ID: 11078212
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aquaporin-4 polymorphisms predict amyloid burden and clinical outcome in the Alzheimer's disease spectrum.
    Chandra A; Farrell C; Wilson H; Dervenoulas G; De Natale ER; Politis M;
    Neurobiol Aging; 2021 Jan; 97():1-9. PubMed ID: 33068891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease.
    Huang SY; Zhang YR; Guo Y; Du J; Ren P; Wu BS; Feng JF; ; Cheng W; Yu JT
    Alzheimers Dement; 2024 May; 20(5):3251-3269. PubMed ID: 38501315
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Astrocytic C-X-C motif chemokine ligand-1 mediates β-amyloid-induced synaptotoxicity.
    Perez-Nievas BG; Johnson L; Beltran-Lobo P; Hughes MM; Gammallieri L; Tarsitano F; Myszczynska MA; Vazquez-Villasenor I; Jimenez-Sanchez M; Troakes C; Wharton SB; Ferraiuolo L; Noble W
    J Neuroinflammation; 2021 Dec; 18(1):306. PubMed ID: 34963475
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A role for astrocyte-derived amyloid β peptides in the degeneration of neurons in an animal model of temporal lobe epilepsy.
    Kodam A; Ourdev D; Maulik M; Hariharakrishnan J; Banerjee M; Wang Y; Kar S
    Brain Pathol; 2019 Jan; 29(1):28-44. PubMed ID: 29665128
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Astrocyte and Alzheimer's disease.
    Cai Z; Wan CQ; Liu Z
    J Neurol; 2017 Oct; 264(10):2068-2074. PubMed ID: 28821953
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhancing astrocytic lysosome biogenesis facilitates Aβ clearance and attenuates amyloid plaque pathogenesis.
    Xiao Q; Yan P; Ma X; Liu H; Perez R; Zhu A; Gonzales E; Burchett JM; Schuler DR; Cirrito JR; Diwan A; Lee JM
    J Neurosci; 2014 Jul; 34(29):9607-20. PubMed ID: 25031402
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-intensity interval training ameliorates Alzheimer's disease-like pathology by regulating astrocyte phenotype-associated AQP4 polarization.
    Feng S; Wu C; Zou P; Deng Q; Chen Z; Li M; Zhu L; Li F; Liu TC; Duan R; Yang L
    Theranostics; 2023; 13(10):3434-3450. PubMed ID: 37351177
    [No Abstract]   [Full Text] [Related]  

  • 55. Suppression of glymphatic fluid transport in a mouse model of Alzheimer's disease.
    Peng W; Achariyar TM; Li B; Liao Y; Mestre H; Hitomi E; Regan S; Kasper T; Peng S; Ding F; Benveniste H; Nedergaard M; Deane R
    Neurobiol Dis; 2016 Sep; 93():215-25. PubMed ID: 27234656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma Oligomer β-Amyloid and White Matter Microstructural Integrity in Cognitively Normal Older Adults According to Cerebral Amyloid Deposition.
    Wang SM; Kang DW; Um YH; Kim S; Lee CU; Scheltens P; Lim HK
    J Prev Alzheimers Dis; 2023; 10(4):837-846. PubMed ID: 37874106
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Calcium-sensing receptor antagonist (calcilytic) NPS 2143 specifically blocks the increased secretion of endogenous Aβ42 prompted by exogenous fibrillary or soluble Aβ25-35 in human cortical astrocytes and neurons-therapeutic relevance to Alzheimer's disease.
    Armato U; Chiarini A; Chakravarthy B; Chioffi F; Pacchiana R; Colarusso E; Whitfield JF; Dal Prà I
    Biochim Biophys Acta; 2013 Oct; 1832(10):1634-52. PubMed ID: 23628734
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
    Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
    Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ultrasound-mediated augmented exosome release from astrocytes alleviates amyloid-β-induced neurotoxicity.
    Deng Z; Wang J; Xiao Y; Li F; Niu L; Liu X; Meng L; Zheng H
    Theranostics; 2021; 11(9):4351-4362. PubMed ID: 33754065
    [No Abstract]   [Full Text] [Related]  

  • 60. Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate.
    Yang T; Li S; Xu H; Walsh DM; Selkoe DJ
    J Neurosci; 2017 Jan; 37(1):152-163. PubMed ID: 28053038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.